Search research articles
Contact Us
Filters
Showing results (211-220 of 323) with videos related to
Page
of 33
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2018
Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia
Na Li, Michael A Lopez, Maria Linares, et al.
Seminars in Hematology
|
May 12, 2023
Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria
Steven P Treon, Alessandra Tedeschi, Jesus San-Miguel, et al.
Hemasphere
|
July 11, 2020
Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical Trials
Jorge J Castillo, Joshua N Gustine, Kirsten Meid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia
Meletios Athanasios Dimopoulos, Morie A Gertz, Efstathios Kastritis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 26, 2018
Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström Macroglobulinemia
Steven P Treon, Joshua Gustine, Kirsten Meid, et al.
Blood
|
June 16, 2016
Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemia
Zachary R Hunter, Lian Xu, Guang Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2015
Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T Cells
Julie S Nielsen, Colin G Sedgwick, Aniqa Shahid, et al.
Blood
|
April 17, 2010
Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma
Rao H Prabhala, Dheeraj Pelluru, Mariateresa Fulciniti, et al.
Blood Advances
|
January 16, 2026
Quantitative MYD88L265P and CXCR4S338X analysis to assess clinical trial performance in Waldenstrom Macroglobulinemia
Nickolas Tsakmaklis, Zachary R Hunter, Xia Liu, et al.
Seminars in Hematology
|
May 29, 2025
Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk disease
Prashant Kapoor, Meletios A Dimopoulos, Stephen M Ansell, et al.
Page
of 33
Search research articles
Search
Showing results (211-220 of 323) with videos related to
Sort By:
Page
of 33
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2018
Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia
Na Li, Michael A Lopez, Maria Linares, et al.
Seminars in Hematology
|
May 12, 2023
Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria
Steven P Treon, Alessandra Tedeschi, Jesus San-Miguel, et al.
Hemasphere
|
July 11, 2020
Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical Trials
Jorge J Castillo, Joshua N Gustine, Kirsten Meid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia
Meletios Athanasios Dimopoulos, Morie A Gertz, Efstathios Kastritis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 26, 2018
Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström Macroglobulinemia
Steven P Treon, Joshua Gustine, Kirsten Meid, et al.
Blood
|
June 16, 2016
Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemia
Zachary R Hunter, Lian Xu, Guang Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2015
Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T Cells
Julie S Nielsen, Colin G Sedgwick, Aniqa Shahid, et al.
Blood
|
April 17, 2010
Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma
Rao H Prabhala, Dheeraj Pelluru, Mariateresa Fulciniti, et al.
Blood Advances
|
January 16, 2026
Quantitative MYD88L265P and CXCR4S338X analysis to assess clinical trial performance in Waldenstrom Macroglobulinemia
Nickolas Tsakmaklis, Zachary R Hunter, Xia Liu, et al.
Seminars in Hematology
|
May 29, 2025
Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk disease
Prashant Kapoor, Meletios A Dimopoulos, Stephen M Ansell, et al.
Page
of 33